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1. Introduction 
Vaccinium bracteatum Thunb. (Ericaceae), known as “Nan 
Zhu” in Chinese, is an evergreen shrubby tree distributed in 
mountainous regions of southern China and recognized as an 
edible and also a medicinal product for use in daily life. Its fruits 
(“Nan Zhu Zi”), like cranberry and blueberry, can be used as a 
fruit or beverage material. Its leaves have been used for cooking 
since the Tang Dynasty, and now it has been a tradition to eat this 
kind of food during the “Qing Ming Festival” in the south of 
China. As V. bracteatum was reported to possess significant 
health benefits, such as antifatigue, antianemia, antioxidant and 
immunomodulate effects,1 an array of phytochemical 
investigations have been conducted, revealing the existence of 
fatty acids, flavonoids and triterpenes as the main chemical 
components.2,3 Iridoid glucosides have also been reported as one 
type of minor constitutes from this plant.4-6 
Iridoids display an interesting spectrum of biological activity 
such as cardiovascular,7,8 antihepatotoxic,9 antiinflammatory10,11 
and antiviral activities.12 In order to search for more iridoid 
compounds, a thorough investigation of the leaves of Vaccinium 
bracteatum was carried out. Two novel lignan-iridoid glucoside 
diesters (compounds 2-3, Fig. 1), together with their putative 
biosynthetic precursor (1), were isolated and characterized using 
spectroscopic measurements, DFT C-NMR calculations, and 
time-dependent density functional theory (TDDFT) electronic 
circular dichroism (ECD) calculations. In this study, we report 
the isolation, structural elucidation of these three new 
compounds, and the proposed biosynthetic pathway as well. 
2. Results and discussion 
The air-dried leaves of V. bracteatum were ground into 
powder, and then extracted three times with 95% ethanol under 
ambient temperature to afford a crude extract. The extract was 
further partitioned in water, and then extracted with petroleum 
ether (PE) and EtOAc, successively, to give a PE, an EtOAc, and 
a water soluble fraction. The water soluble fraction was then 
fractionated by repeated column chromatography (CC) over 
macroporous resin AB-8 gel, polyamide, octadecyl silane (ODS), 
Sephadex LH-20, and finally preparative or semipreparative 
HPLC to yield compounds 1-3. 
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Fig. 1. Structures of compounds 1−3. 
Compound 1 was obtained as yellow amorphous powder and 
its molecular formula was assigned to be C25H30O15 from the 
pseudo-molecular positive ion at m/z 593.1494 [M + Na]+ (calcd. 
for C25H30NaO15, 593.1477) in the HRESIMS, requiring 11 
degrees of unsaturation. The IR spectrum indicated the presence 
of hydroxyl (3430 cm–1), conjugated carbonyl (1732 cm–1) and 
aromatic (1636, 1528 cm–1) groups. The 1H and 13C NMR data of 
1 (Tables 1 and 2) displayed characteristic signals of an iridoid 
 
Fig. 2. Key HMBC (H C) correlations of 1. 
 
glucoside.13-16 The 13C NMR and DEPT spectra revealed 25 
carbon resonances including ten ascribed to a 10-carbon iridoid 
skeleton (δC 171.4, 154.4, 110.1, 95.5, 80.1, 76.8, 71.7, 45.8, 
45.1, 42.0), six to a glucopyranosyl unit (δC 100.4, 78.3, 77.9, 
74.6, 71.2, 62.5), and nine to a caffeoyl group17 (δC 169.2, 149.6, 
147.4, 146.8, 127.7, 123.1, 116.5, 115.2, 114.9). These signals 
showed high similarities to those reported for the known 
compound 10-O-trans-p-coumaroyl-6α-hydroxyl-
dihydromonotropein.5 Their NMR data comparison revealed that 
singals of a caffeoyl group instead of a p-coumaroyl group were 
presented in the molecule of 1. The correlations between the 
protons resonating at δH 4.24, 4.34 (H-10) and the ester carbonyl 
at δC 169.2 (C-1") of the caffeoyl group were observed in the 
HMBC spectrum (Fig. 2), suggesting that the caffeoyl group was 
attached to C-10 of the iridoid skeleton. The absolute 
configuration of the glucose was determined as D-glucose 
according to the method described in the literature18 (see 
supporting information). Therefore, the structure of 1 was 
determined to be 10-O-trans-caffeoyl-6α-hydroxyl-
dihydromonotropein. 
    Compound 2, obtained as yellow amorphous powder, had a 
molecular formula of C50H58O30 with 22 double-bond equivalents 
 
Table 1 
1H NMR Data for Compounds 1−3. 
a Recorded in methanol-d4 at 500 MHz, b Recorded in methanol-d4 at 600 MHz, δ in ppm, J in Hz. 
   
2b 
 
3b 
no. 1a  Unit I  Unit II   Unit I Unit II 
1 5.67 (d, 3.3)  5.55 (d, 4.1) 5.46 (d, 4.2)  5.59 (d, 3.7) 5.46 (d, 3.9) 
3 7.55 (br s)  7.52 (br s) 7.48 (br s)  7.51 (br s) 7.48 (br s) 
5 2.91 (dd, 9.6, 4.0)  2.85 (dd, 9.7, 4.6) 2.67 (dd, 10.0, 5.4)  2.87 (dd, 9.7, 4.5) 2.74 (dd, 10.0, 5.0) 
6 4.38 (q, 5.3)  4.29 (m) 4.18 (m)  4.31 (q, 5.6) 4.22 (m) 
7 1.95 (dd, 13.8, 5.6) 2.04 (dd, 13.8, 5.6)  
1.92 (dd, 13.7, 6.7) 
2.02 (dd, 13.7, 5.7) 
1.72 (dd, 13.4, 7.3) 
1.89 (dd, 13.4, 5.9)  
1.91 (dd, 13.6, 6.0) 
2.02 (dd, 13.6, 5.7) 
1.75 (dd, 13.6, 7.4) 
1.91 (dd, 13.6, 6.0) 
9 2.68 (dd, 9.6, 3.3)  2.55 (dd, 9.7, 4.1) 2.24 (dd, 10.0, 4.2)  2.60 (dd, 9.7, 3.7) 2.34 (dd, 10.0, 3.9) 
10 4.24 (d, 11.2) 4.34 (d, 11.2)  
4.18 (d, 11.1)  
4.30 (d, 11.1) 
4.03 (d, 11.1) 
4.13 (d, 11.1)  
4.21 (d, 11.2) 
4.27 (d, 11.2) 
4.04 (d, 11.1) 
4.14 (d, 11.1) 
1′ 4.71 (d, 7.9)  4.69 (d, 7.9) 4.66 (d, 7.9)  4.68 (d, 7.9) 4.64 (d, 7.9) 
2′ 3.23 (t, 8.3)  3.24 (m) 3.25 (m)  3.26 (m) 3.24 (m) 
3′ 3.38 (m)  3.35 (m) 3.36 (m)  3.36 (m) 3.34 (m) 
4′ 3.32 (m)  3.32 (m) 3.35 (m)  3.32 (m) 3.34 (m) 
5′ 3.31 (m)  3.30 (m) 3.30 (m)  3.32 (m) 3.28 (m) 
6′ 3.68 (dd, 12.0, 4.7) 3.86 (dd, 12.0, 1.8)  
3.65 (m) 
3.82 (m) 
3.61 (m) 
3.79 (m)  
3.62 (m) 
3.81 (m) 
3.64 (m) 
3.78 (m) 
2" 6.35 (d, 15.9)   3.99 (d, 3.3)   3.98 (d, 3.4) 
3" 7.63 (d, 15.9)  7.71 (s) 4.45 (d, 3.3)  7.74 (s) 4.46 (d, 3.4) 
5" 7.10 (d, 2.1)  6.88 (s) 6.46 (d, 2.2)  6.88 (s) 6.45 (m) 
8" 6.81 (d, 8.2)  6.57 (s) 6.63 (d, 8.2)  6.55 (s) 6.64 (d, 8.7) 
9" 7.00 (dd, 8.3, 2.1)   6.42 (dd, 8.2, 2.2)   6.45 (m) 
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Table 2 
13C NMR Data for Compounds 1−3. 
Recorded in methanol-d4 at 125 MHz, δ in ppm. 
(DBEs) as determined by the HRESIMS. The IR spectrum 
showed absorption bands for hydroxyl (3428 cm–1), conjugated 
carbonyl (1730 cm–1) and aromatic (1640, 1526 cm–1) 
functionalities. Analysis of the 1H and 13C NMR data with the aid 
of DEPT experiment revealed the presence of two sets of iridoid 
glucoside signals, similar to those of 1 (Tables 1 and 2). The 
remaining signals included those of two doublet methine protons 
(δH 3.99 and δH 4.45) and a singlet olefinic proton (δH 7.71), 
corresponding to two methine carbons (δC 49.4 and δC 46.9) and 
one olefinic carbon (δC 140.4). In addition, signals at δH 6.63 
(1H, d, J = 8.2), 6.46 (1H, d, J = 2.2) and 6.42 (1H, dd, J = 8.2, 
2.2), indicative of an aromatic ring with a typical ABX spin 
system, and two singlet signals at δH 6.88 and 6.57, 
corresponding to carbons at 117.3 and 117.5 and assigned as two 
para-positioned aromatic protons of another aromatic ring, were 
observed. The HMBC correlations (Fig. 3) from δH 3.99 (H-2", 
unit II) to δC 168.6 (C-1", unit I), 140.4 (C-3", unit I), 135.7 (C-
4", unit II)，? and 131.3 (C-9", unit I), and from δH 4.45 (H-3", 
unit II) to δC 174.5 (C-1", unit II), 124.9 (C-4", unit I), 122.4 (C-
2", unit I), 115.9 (C-5", unit II), and 117.5 (C-8", unit I), and 
from δH 7.71 (H-3", unit I) to δC 117.3 (C-5", unit I), along with 
the assignment information aforementioned, revealed the 
presence of a lignan group.19,20 This lignan group and the iridoid 
glucoside moieties was finally connected by ester groups, which 
was deduced from the HMBC correlations of the methylene 
protons (H-10) to the carbonyl carbon (C-1"). Therefore, 
compound 2 was established as a lignan-iridoid glycoside diester. 
 
 
   
 
Fig. 3. 1H–1H COSY ( ), key HMBC (H C) and ROESY 
(H H) correlations of compound 2. 
 
The moderate 3J2"-H,3"-H coupling constant (3.3 Hz) of 2 
suggested either cis21-23 relative configuration of the C-2 and C-
3 substituents provided that one of them is equatorial, while the 
other is axial or trans19,20,24 relative configuration provided that 
both of them is axial. However, correlations between H-2 (unit 
II) and H-9 (unit II), and between H-3" and H-8" in the ROESY 
spectrum (Fig. 3) suggested a trans relative configuration 
between H-2 (unit II) and H-3 (unit II). 25,26 To further confirm 
both the relative and the absolute configuration of those two 
chirality centers of the lignan moiety, ECD and C-NMR 
calculations were performed on a model compound (vide infra). 
Compound 3 was obtained as yellow amorphous powder. The 
HRESIMS indicated a molecular formula of C50H58O30 (m/z 
1137.2948, calcd for C50H57O30, 1137.2940), the same as that of 
2. Its IR spectrum indicated the existence of hydroxyl (3424 cm–
1), conjugated carbonyl (1726 cm–1) and aromatic (1638, 
1527cm–1) groups. The NMR data of 3 (Tables 1 and 2) showed 
high similarities to those of compound 2, suggesting that the 
molecule of 3 also contained two iridoid glucoside moieties and a 
lignan moiety. A detailed comparison of 1D and 2D NMR data of 
these two compounds further confirmed that these two 
compounds shared the same planar structure and relative 
configuration, and only differed at the stereochemistry of C-2" 
and C-3" of unit II.  
 
 
 
Fig. 4. Experimental ECD spectra of compounds 1−3 recorded in 
MeOH. 
  2 3 
no 1 Unit Unit Unit Unit 
1 95.5 95.6 95.6 95.4 95.5 
3 154.4 154.2 154.0 154.0 153.8
4 110.1 110.5 110.8 110.6 111.3 
5 42.0 42.3 42.2 42.2 42.2 
6 76.8 77.1 77.3 77.1 77.4 
7 45.1 45.1 44.9 45.1 45.1 
8 80.1 80.0 79.8 80.1 79.7 
9 45.8 45.7 45.0 45.7 45.3 
10 71.7 71.6 70.5 71.8 70.5 
11 171.4 171.8 172.0 171.8 172.1 
1′ 100.4 100.6 100.4 100.4 100.1 
2′ 74.6 74.5 74.5 74.5 74.5 
3′ 77.9 77.9 77.9 77.9 77.9 
4′ 71.2 71.3 71.3 71 .3 71.3 
5′ 78.3 78.3 78.3 78.3 78.3 
6′ 62.5 62.6 62.6 62.6 62.6 
1" 169.2 168.6 174.5 168.6 174.4 
2" 114.9 122.4 49.4 122.3 49.2 
3" 147.4 140.4 46.9 140.5 46.9 
4" 127.7 124.9 135.7 124.8 135.8 
5" 115.2 117.3 115.9 117.5 115.9 
6" 146.8 145.7 146.1 145.7 146.1 
7" 149.6 149.3 145.1 149.4 145.1 
8" 116.5 117.5 116.4 117.3 116.4 
9" 123.1 131.3 120.1 131.4 120.1 
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Fig. 5. Structure of truncated model compounds 4a and 4b. 
 
In order to determine the relative and the absolute 
configuration of C-2" and C-3" of the lignan moiety, first the 
ECD spectra of 2 and 3 in MeOH were recorded, showing 
opposite Cotton effects (CEs) at 293, 315 and 350 nm and the 
same negative CEs around 245 nm (Fig. 4). Due to the high 
conformational flexibility and large molecular weight of 2 and 3, 
a large number of low-energy conformational isomers are 
expected in the conformational search, the optimization and ECD 
calculation of which would impose high uncertainty in the 
determination of the absolute configuration.27,28 Since the three 
high-wavelength transitions (above 280 nm) of 2 and 3 could be 
attributed to the trisubstituted 1,2-dihidronaphthalene unit and the 
iridoid moieties contain only α,β-unsaturated carboxylic acid 
chromophores, the truncated model compounds 4a and 4b with 
trans and cis relative configurations, respectively, could be used 
for the ECD calculations, in which the complex ester groups are 
simplified to methyl esters (Fig. 5).27,29 The experimental ECD 
spectrum of 1 had a single negative ECD transition at ca. 245 nm 
justifying the truncation (Fig. 4).  
Thus the conformationally flexible iridoid part was truncated 
and model compounds 4a and 4b with a (2"R, 3"S) and a (2"R, 
3"R) absolute configurations were selected for conformational 
analysis and ECD calculations. The Merck Molecular Force Field 
(MMFF) conformational search of the model compound 4a 
resulted in 46 low-energy conformers within a 21 kJ/mol energy 
window and 73 conformers for 4b. These conformers were 
reoptimized at the B3LYP/6-31G(d) level in vacuo, the 
B97D/TZVP30,31 PCM/MeOH and the CAM-B3LYP/TZVP32,33 
PCM/MeOH levels providing eight low-energy conformers (≥ 
1%) at each level for 4a (Fig. 6) and 14, 16 and 16 low-energy 
conformers for 4b (Fig. 7). It is interesting to note that both 
substituents of 4a (C-2" and C-3") adopted axial orientation in all 
the low-energy conformers, while for 4b the  
 
 
Fig. 6. Structure and population of the low-energy B3LYP/6-
31G(d) conformers of 4a. 
 
Fig. 7. Structure and population of the low-energy B3LYP/6-
31G(d) conformers of 4b. 
 
C-2" substituent had axial orientation and the C-3" one equatorial 
in most of the conformers (ca. 88.2% overall population vs. 
10.6% for equatorial C-2" and axial C-3"). With these orientation 
of C-2" and C-3" substituents, the small value of 3J2"-H,3"-H and 
NOE correlations did not allow distinguishing the cis and trans 
relative onfiguration. ECD spectra computed at various levels for 
all sets of conformers for both trans and cis model compounds of 
4a (Fig. 8) and 4b (Fig. 9) reproduced the main features of the 
experimental spectrum of 3 down to ca. 235 nm (the highest-
energy experimental 247 nm transition is an overlap of the core 
part and the truncated parts) with the best agreement at the 
PBE0/TZVP level on the gas-phase conformers. Although 
relative configuration of C-2" and C-3" could not be determined 
on the basis of the above ECD results, the consistent results 
obtained at various levels for both diastereomers allowed the 
elucidation of the absolute configuration of C-2" of the 1,2-
dihidronaphthalene moiety as (R) in 3 and (S) in 2.  
 
 
 
Fig. 8. Experimental ECD spectrum of 3 compared with the 
Boltzmann-weighted PBE0/TZVP ECD spectrum of model 
compound 4a computed for the B3LYP/6-31G(d) conformers. 
Bars represent the rotational strengths of conformer A. 
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Fig. 9. Experimental ECD spectrum of 3 compared with the 
Boltzmann-weighted PBE0/TZVP ECD spectrum of model 
compound 4b computed for the B3LYP/6-31G(d) conformers. 
Bars represent the rotational strengths of conformer A. 
 
In order to determine the relative configuration of the two 
chirality centers and hence the absolute configuration, C-NMR 
calculations were performed on the same model compounds at 
the mPW1PW91/6-311+G(d,p) level34 computing for the low-
energy B3LYP/6-31+G(d,p) reoptimized MMFF conformers. 
Table 3 summarizes the results; from 11 relevant carbons 
(including ring B and the first connecting carbon atoms) in the 
vicinity of the two chirality centers, 9 suggested trans and only 2 
cis relative configuration. On the basis of the deviations and 
average errors, the trans relative configuration could be 
determined and thus (2"S,3"R)-2 and (2"R,3"S)-3 absolute 
configurations could be elucidated.41,43,44 The C-NMR results are 
in line with the computed J values, which also indicated trans 
relative configuration (see SI for details) in line with the ROESY 
correlations making elucidation of the relative and absolute 
configuration solid. Based on the above results, it is advisable to 
similarly prove the cis relative configuration of other 
tetrahydronaphthalene lignans having moderate J values. 
 
Table 3 
Comparison of the computed C-NMR data of 11 relevant carbons 
in the vicinity of the two chirality centers of model compounds 
4a and 4b with the experimental 13C-NMR data. Average ∆δtrans 
= 1.20 while average ∆δcis = 2.24 suggesting trans relative 
configuration. 
 
 
 
 
 
Scheme 1. Proposed biosynthetic pathways for compounds 2 and 
3. 
 
On the basis of literatures and our findings, the biosynthetic 
pathways of 2 and 3 could be proposed (Scheme 1). In brief, the 
mechanism might involve an esterification reaction between 
caffeic acid and iridoid to produce compound 1. One-electron 
oxidation, resonance hybridization and dimerization of 1 results 
in bimolecular radical coupling to yield 1a.35,36 Intermediate 1a 
underwent a rearrangement reaction, and then further constructed 
the bicyclic ring system to afford 2 and 3. 
3. Conclusions 
In summary, three novel iridoid glucoside derivatives were 
isolated and characterized from the leaves of V. bracteatum. 10-
O-trans-caffeoyl-6α-hydroxyl-dihydromonotropein (1) is the first 
iridoid glucoside from the genus Vaccinium that contains a 
caffeoyl group instead of a p-coumaroyl group while compounds 
2 and 3 represent a new type of compounds that is lignan-iridoid 
glucoside diesters. Furthermore, for the first time, DFT NMR and 
TDDFT ECD calculation was applied to the relative and absolute 
configuration determination of this kind of lignan derivatives. 
4. Experimental Section 
4.1. General experimental procedures 
TLC was carried out on precoated silica gel 60 F254 25 
Aluminium sheets (Merck KGaA, Darmstadt, Germany) and the 
TLC spots were viewed at 254 nm and visualized with 5% H2SO4 
in EtOH containing 10 mg/mL vanillin. Macro porous resin AB-8 
gel (Shandong Lu Kang Chemical Industrials, Jinan, Shandong, 
China), ODS (YMC Co., Ltd., Japan), and Sephadex LH-20 
(Pharmacia Biotech AB, Uppsala, Sweden) were used for column 
chromatography (CC). Analytical HPLC was applied on a Waters 
2695 instrument (Milford, MD, USA) coupled with a 2998 PDA, 
a Waters 2424 ELSD, and a Waters 3100 MS detector. 
Preparative HPLC was performed on a Varian PrepStar 
carbon exp (3) calcd 4a (trans) calcd 4b (cis) ∆δtrans ∆δcis 
UI-1'' 168.6 167.51 167.36 1.09 1.24 
UI-2'' 122.3 123.91 125.16 1.61 2.86 
UI-3'' 140.5 139.58 141.98 0.92 1.48 
UI-4'' 124.8 127.45 126.42 2.65 1.62 
UI-5'' 117.5 114.85 114.29 2.65 3.21 
UI-8'' 117.3 114.62 115.05 2.68 2.25 
UI-9'' 131.4 132.15 135.16 0.75 3.76 
UII-1'' 174.4 174.64 173.79 0.24 0.61 
UII-2'' 49.2 49.15 48.44 0.05 0.76 
UII-3'' 46.9 47.26 50.49 0.36 3.59 
UII-4'' 135.8 135.95 132.49 0.15 3.31 
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instrument with an Alltech 3300 ELSD detector (Columbia, 
MD, USA) using a Waters Sunfire RP C18, 5 µm, 30 × 150 mm 
column. Semipreparative HPLC was performed on a Waters 
2690 instrument (Milford, MD, USA) coupled with a 996 
photodiode array detector using a YMC-pack RP C18, 5 µm, 10 
× 250 mm column. Optical rotations were measured on a 
Rudolph Autopol VIAutomatic polarimeter (Hackettstown, NJ, 
USA). IR spectra were recorded on a Nicolet Magna FT-IR 750 
spectrophotometer (Waltham, MA, USA) using KBr disks. ECD 
spectra were recorded on a JASCO J-810 spectrometer. ESIMS 
and HRESIMS data were recorded on Waters 2695-3100 LC-MS 
and Agilent G6520 Q-TOF mass spectrometers (Santa Clara, CA, 
USA), respectively. NMR spectra were recorded on a Bruker 
Avance III (Bruker, Zurich, Switzerland) for 500 and 600 M 
NMR spectrometer with TMS as internal standard. The chemical 
shift (δ) values were given in ppm and coupling constants (J) are 
in Hz. All solvents used for CC were of at least analytical grade 
(Shanghai Chemical Reagents Co., Ltd., Shanghai, China), and 
solvents used for HPLC were of HPLC grade (Merck KGaA, 
Darmstadt, Germany). 
4.2. Plant material 
The leaves of V. bracteatum were collected in Jiangsu 
Province, China, in 2015, and identified by Professor Jin-Gui 
Shen from Shanghai Institute of Materia Medica. A voucher 
specimen (No. 20150926) was deposited at the Herbarium of the 
Shanghai Institute of Materia Medica, Chinese Academy of 
Sciences. 
4.3. Extraction and isolation 
The air-dried leaves of V. bracteatum (20 kg) were ground 
into powder, and then extracted three times with 95% ethanol at 
room temperature to afford a crude extract (1.5 kg). The extract 
was further partitioned in water, and then extracted with 
petroleum ether (PE) and EtOAc, successively, to give a PE, an 
EtOAc, and a water soluble fraction. The water soluble fraction 
(Fr. A) was then fractionated by a column chromatography (CC) 
over macroporous resin AB-8 gel (EtOH/H2O, from 30 to 95%), 
yieling fractions A1−A3. Fraction A1 (200 g) was then separated 
on polyamide (MeOH/H2O, from 20 to 95%) to give four 
subfractions (A1A-A1D). Then subfraction A1A was subjected 
to CC over octadecyl silane (ODS) (MeOH/H2O, from 10 to 
45%) to afford fractions A1A1-A1A10. Fraction A1A1 (180.0 
mg) was applied to preparative HPLC (MeOH/H2O, from 5 to 
20%, containing 0.2% formic acid; 0-120 min, 25 mL/min) and 
then semipreparative HPLC (MeCN/H2O, from 9 to 14%, 
containing 0.2% formic acid; 0-60 min, 3 mL/min) to afford 
compounds 2 (3.2 mg) and 3 (2.4 mg) as trace components. 
Fraction A1A4 (2.0 g) was chromatographed on Sephadex LH-20 
(MeOH) to yield subfractions A1A4C (800 mg). Finally, 
compound 1 (115 mg) was obtained from fraction A1A4C by 
preparative HPLC (MeCN/H2O, from 10 to 28%, containing 
0.2% formic acid; 0-120 min, 25 mL/min). 
4.3.1. Determination of sugar configuration 
Compound 1 (11.4 mg) and cellulase (11.4 mg) were 
dissolved in HOAc – NaOAc buffered solution (PH = 4.5, 2 mL) 
and stirred at room temperature for a week. The reaction mixture 
was evaporated by rotary evaporator, and then dissolved in 
pyridine (2 mL) containing L-cysteine methyl ester 
hydrochloride (2 mg) and heated at 60 °C for 60 min. Then o-
tolyl isothiocyanate (5 µL) was added to the mixture and heated 
at 60 °C for 60 min. After evaporation of the solvent, the residue 
was dissolved in methanol, and then analyzed by LCMS. The 
authentic D/L-glucose samples were treated with the same method 
aforementioned, and analyzed by LCMS, too. The retention time 
of the derivatives of compound 1, D-glucose  and L-glucose were 
13.13, 13.17 and 12.42 min, respectively. Therefore, the sugar 
moiety of compound 1 was determined as D-glucose (details see 
Supporting Information). 
4.3.2. Compound characteristics 
Compound 1 
 yellow amorphous powder; [α]D20 –69.7 (c = 1.5, MeOH); UV 
(MeOH) λmax (log ε) 324 (4.06), 219 (4.15) nm; ECD (MeOH) 
(∆ε) 244 (–2.16) nm; IR (KBr, cm–1): νmax 3430, 1732, 1636, 
1528 cm–1; 1H and 13C NMR data, see Tables 1 and 2; ESIMS 
m/z 569 [M – H]–; HRESIMS m/z 593.1494 [M + Na]+ (calcd. 
For C25H30NaO15, 593.1477). 
Compound 2 
 yellow amorphous powder; [α]D20 –72.5 (c = 0.13, MeOH); 
UV (MeOH) λmax (log ε) 342 (2.80), 315 (2.73), 290 (2.66), 230 
(3.25) nm; ECD (MeOH) (∆ε) 348 (–2.30), 315 (0.93), 293 (–
0.79), 240 (–5.85), nm; IR (KBr, cm–1): νmax 3428, 1730, 1640, 
1526 cm–1; 1H and 13C NMR data, see Tables 1 and 2; ESIMS 
m/z 1137 [M – H]–; HRESIMS m/z 1137.2955 [M – H]– (calcd. 
for C50H57O30, 1137.2940). 
Compound 3 
 yellow amorphous powder; [α]D20 +11.4 (c = 0.098, MeOH); 
UV (MeOH) λmax (log ε) 344 (2.64), 312 (2.62), 292 (2.57), 230 
(3.07) nm; ECD (MeOH) (∆ε) 348 (2.21), 314 (–0.52), 293 
(1.00), 247 (–5.74) nm; IR (KBr, cm–1): νmax 3424, 1726, 1638, 
1527 cm–1; 1H and 13C NMR data, see Tables 1 and 2; ESIMS 
m/z 1137.6 [M – H]–; HRESIMS m/z 1137.2948 [M – H]– (calcd 
for C50H57O30, 1137.2940). 
4.4. Computational section 
Mixed torsional/low-frequencymode conformational searches 
were carried out by means of the Macromodel 10.8.011 software 
using the Merck Molecular Force Field (MMFF) with an implicit 
solvent model for CHCl3.37 Geometry reoptimizations were 
carried out at the B3LYP/6-31G(d) level in vacuo, the B3LYP/6-
31+G(d,p) level in vacuo, the B97D/TZVP30,31 and the 
CAMB3LYP/TZVP32,33 levels with the PCM solvent model for 
MeOH. DFT optimized geometries were clustered for all non-
hydrogen atoms. TDDFT ECD calculations were run with 
various functionals (B3LYP, BH&HLYP, CAM-B3LYP, PBE0) 
and the TZVP basis set as implemented in the Gaussian 09 
package with the same or no solvent model as in the preceding 
DFT optimization step.38 NMR calculations were performed at 
the mPW1PW91/6-311+G(2d,p) level.34 ECD spectra were 
generated as sums of Gaussians with 2400 and 3000 cm−1 widths 
at half-height (corresponding to ca. 15 and 19 nm at 250 nm), 
using dipole-velocity-computed rotational strength values.39 
Computed NMR data were corrected with I = 185.4855 and S = -
1.0306.40,41 Boltzmann distributions were estimated from the 
ZPVE-corrected B3LYP/6-31G(d) energies in the B3LYP/6-
31G(d) gas-phase calculations, and from the uncorrected 
B3LYP/6-31+G(d,p), B97D/TZVP and CAM-B3LYP/TZVP 
energies in the other cases. The MOLEKEL software package 
was used for visualization of the results.42 
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